Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Sonia E, Trojan"'
Publikováno v:
Cancer Cell International, Vol 19, Iss 1, Pp 1-7 (2019)
Abstract Background/Aim During cancer progression metabolic reprogramming is observed in parallel to the alternation in transcriptional profiles of malignant cells. Recent studies suggest that metabolic isoenzymes of phosphofructokinase II (PFK-II)
Externí odkaz:
https://doaj.org/article/26b1ac35ad994e72b6aea9d175bb16ee
Autor:
Paulina Dudzik, Barbara Ostrowska, Małgorzata Lasota, Dorota Kusior, Kinga A. Kocemba-Pilarczyk, Sonia E. Trojan, Marta Kot
Publikováno v:
Pharmacological Reports
Background Multiple myeloma (MM) is defined as plasma cells malignancy, developing in the bone marrow. At the beginning of the disease, the malignant plasma cells are dependent on bone marrow microenvironment, providing growth and survival factors. I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00b50cc67bf5e8dee8f20d28a429405d
http://europepmc.org/articles/PMC7550387
http://europepmc.org/articles/PMC7550387
Autor:
Piotr Laidler, Kinga A. Kocemba-Pilarczyk, Justyna Totoń-Żurańska, Paulina Dudzik, Sonia E. Trojan
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 8848, p 8848 (2021)
Volume 22
Issue 16
International Journal of Molecular Sciences, Vol 22, Iss 8848, p 8848 (2021)
Volume 22
Issue 16
Cancer-specific isoenzyme of phosphofructokinase II (PFKFB4), as our previous research has shown, may be one of the most important enzymes contributing to the intensification of glycolysis in hypoxic malignant melanoma cells. Although the PFKFB4 gene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a3e1a3948a475c4aed79c5f94a92be6
https://doi.org/10.3390/ijms22168848
https://doi.org/10.3390/ijms22168848
Autor:
Barbara Ostrowska, Piotr Laidler, Małgorzata Lasota, Paulina Dudzik, Kinga A. Kocemba-Pilarczyk, Sonia E. Trojan, Joanna Dulińska-Litewka
Publikováno v:
Acta Biochimica Polonica.
The CD146 (also known as MCAM, MUC-18, Mel-CAM) was initially reported in 1987, as a protein crucial for the invasiveness of malignant melanoma. Recently, it has been confirmed that CD146 has been involved in progression and poor overall survival of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb0bbe4b5be1dcdd53225a68c5c6f3d0
https://doi.org/10.18388/abp.2019_2907
https://doi.org/10.18388/abp.2019_2907
Publikováno v:
Cancer Cell International
Cancer Cell International, Vol 19, Iss 1, Pp 1-7 (2019)
Cancer Cell International, Vol 19, Iss 1, Pp 1-7 (2019)
Background/Aim During cancer progression metabolic reprogramming is observed in parallel to the alternation in transcriptional profiles of malignant cells. Recent studies suggest that metabolic isoenzymes of phosphofructokinase II (PFK-II) – PFKFB3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d010ae0c2ac46f1d0e48b1c0d3577a4
https://pubmed.ncbi.nlm.nih.gov/31754349
https://pubmed.ncbi.nlm.nih.gov/31754349
Autor:
Paulina, Dudzik, Sonia E, Trojan, Barbara, Ostrowska, Grzegorz, Zemanek, Joanna, Dulińska-Litewka, Piotr, Laidler, Kinga A, Kocemba-Pilarczyk
Publikováno v:
Anticancer research. 39(5)
During cancer progression cells undergo epithelial-to-mesenchymal transition (EMT). Although EMT is a complex process, recently, it has been reported that CD146 overexpression in prostate cancer cells is sufficient to induce mesenchymal phenotype. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0a6606998037c333b76f7d9d362a31ba
https://pubmed.ncbi.nlm.nih.gov/31092432
https://pubmed.ncbi.nlm.nih.gov/31092432
Autor:
Piotr Laidler, Kinga A. Kocemba-Pilarczyk, Grzegorz Zemanek, Paulina Dudzik, Barbara Ostrowska, Joanna Dulińska-Litewka, Sonia E. Trojan
Background/aim During cancer progression cells undergo epithelial-to-mesenchymal transition (EMT). Although EMT is a complex process, recently, it has been reported that CD146 overexpression in prostate cancer cells is sufficient to induce mesenchyma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5beaace4f57ad2b1f76fd600b62f358a
https://ruj.uj.edu.pl/xmlui/handle/item/125390
https://ruj.uj.edu.pl/xmlui/handle/item/125390
Autor:
Paweł Paśko, Sonia E. Trojan, Shela Gorinstein, Praphan Pinsirodom, Paweł Zagrodzki, Ratiporn Haruenkit, Małgorzata Tyszka-Czochara, Sylwia Bobis-Wozowicz, Jacek Namieśnik, Sumitra Poovarodom
The properties of durian fruit at five stages of ripeness were evaluated and compared. The physicochemical parameters such as titratable acidity (TA) and total soluble solids (TSS) increased, whereas the pH slightly decreased during the ripening proc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b76b3084ea5143ea56abbca16959b9bb
https://ruj.uj.edu.pl/xmlui/handle/item/129202
https://ruj.uj.edu.pl/xmlui/handle/item/129202
Autor:
Piotr Laidler, Barbara Ostrowska, Monika Piwowar, Sonia E. Trojan, Kinga A. Kocemba-Pilarczyk
Background/aim Most melanomas develop in hypoxic conditions. Since hypoxia via HIF-1 induces glycolysis, a process essential for malignant melanoma growth/survival, the goal of this study was to analyze the influence of hypoxia on the expression of H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4be2b3a25f183d509104acc071ccea71
https://ruj.uj.edu.pl/xmlui/handle/item/144856
https://ruj.uj.edu.pl/xmlui/handle/item/144856
Autor:
Ecce Aslan, Małgorzata Lasota, Kinga A. Kocemba-Pilarczyk, Joanna Dulińska-Litewka, Claire Lenouvel, Barbara Ostrowska, Dorota Kusior, Sonia E. Trojan
Publikováno v:
Acta biochimica Polonica. 65(1)
Multiple myeloma (MM) is characterized as a clonal expansion of malignant plasma cells in the bone marrow, which is often associated with pancytopenia and osteolytic bone disease. Interestingly, myeloma-infiltrated bone marrow is considered to be hyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87044a097a135437bddb45848839ed64
https://pubmed.ncbi.nlm.nih.gov/29543923
https://pubmed.ncbi.nlm.nih.gov/29543923